Vivani Medical Warrants
VANIW
VANIW was delisted on the 8th of September, 2022.
8 hedge funds and large institutions have $1.76M invested in Vivani Medical Warrants in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 3 closing their positions.
78% more capital inflows, than outflows
Capital inflows: $7.39K | Capital outflows: $4.15K
20% less funds holding
Funds holding: 10 → 8 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$7.39K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Anson Funds Management
Dallas,
Texas
|
-$2.35K |
| 2 |
Edge Wealth Management
New York
|
-$1K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$796 |
VANIW Hedge Fund Activity: Q3 2017 in Review
8 of the 4,024 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical Warrants (VANIW) for Q3 2017, worth a combined $1.76M — down 6% from $1.87M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of VANIW and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was Nomura Holdings, opening a new position worth an estimated $7.39K. The largest seller was Anson Funds Management, cutting an estimated $2.35K.
- 8 institutional investors held Vivani Medical Warrants (VANIW) as of Q3 2017, down from 10 in Q2 2017.
- Funds reported $1.76M of Vivani Medical Warrants stock for Q3 2017, down 6% quarter-over-quarter.
- 1 fund opened new Vivani Medical Warrants positions in Q3 2017 and 3 closed out, a net change of -2 holders.
- The largest Vivani Medical Warrants buyer in Q3 2017 was Nomura Holdings, an estimated $7.39K added.
- The largest Vivani Medical Warrants seller in Q3 2017 was Anson Funds Management, an estimated $2.35K sold.
Based on aggregated 13F filings for Q3 2017.